Refine
Year of publication
- 2012 (13) (remove)
Document Type
Conference Type
- Konferenz-Abstract (7)
- Konferenzartikel (3)
Is part of the Bibliography
- yes (13)
Keywords
- Herzschrittmacher (2)
- Kardiale Resynchronisationstherapie (2)
- Signaltechnik (2)
- AV-Delay (1)
- CRT (1)
- Defibrillator (1)
- Elektrokardiogramm (1)
- Herzinsuffizienz (1)
- Herzmuskelkrankheit (1)
- Telemetrie (1)
Institute
Open Access
- Open Access (12)
- Closed Access (1)
New frontiers of supraventricular tachycardia and atrial flutter evaluation and catheter ablation
(2012)
Radiofrequency catheter ablation (RFCA) has revolutionized treatment for tachyarrhythmias and has become first-line therapy for some tachycardias. Although developed in the 1980s and widely applied in the 1990s, the technique is still in development. Transesophageal atrial pacing (TAP) can used for initiation and termination of supraventricular tachycardia (SVT).
Methods: The paroxysmal SVT include a wide spectrum of disorders including, in descending order of frequency, atrial flutter, atrioventricular (AV) nodal reentry, Wolff-Parkinson-White syndrome, and atrial tachycardia. While not life-threatening in most cases, they may cause important symptoms, such as palpitations, chest discomfort, breathlessness, anxiety, and syncope, which significantly impair quality of life. Medical therapy has variable efficacy, and most patients are not rendered free of symptoms. Research over the past several decades has revealed fundamental mechanisms involved in the initiation and maintenance of all of these arrhythmias. Knowledge of mechanisms has in turn led to highly effective surgical and catheter-based treatments. The supraventricular arrhythmias and their treatment are described in this report. SVT initiation was analysed with programmed TAP in 49 patients with palpitations (age 47 ± 17 years, 24 females, 25 males).
Results: In comparison to antiarrhythmic drug therapy the radiofrequency catheter ablation in patients suffering from atrial flutter, atrioventricular nodal reentry, atrioventricular reentry and atrial tachycardia is the better choice in most cases. TAP SVT initiation was possible in 23 patients before RFCA. Atrial cycle length of SVT was 320 ± 59 ms. We initiated AV nodal reentrant tachycardia (AVNRT, n=15), atrial tachycardia (AT, n=6) and AV reentrant tachycardia with Kent pathway conduction (AVRT, n=2) before RFCA.
Conclusions: Radiofrequency catheter ablation is a successful and safe method to cure most patients with paroxysmal supraventricular tachycardias. TAP allowed initiation and termination of SVT especially in outpatients.
Für den Erfolg einer kardialen Resynchronisationstherapie der Herzinsuffizienz mit biventrikulär stimulierenden Implantaten ist deren individuelle Programmierung von erfolgsbestimmender Bedeutung. Dies trifft insbesondere auf den Parameter AV-Delay zu. Dessen Optimierung durch Echo-Verfahren ist zeitaufwendig, die Suche nach einfacheren Methoden darum verständlich. Eine solche verspricht der in St. Jude Aggregate implementierte automatische QuickOpt Algorithmus. In-vitro-Untersuchungen unter Einsatz eines elektronischen Herzsimulators sagten jedoch verschiedene ungünstige Eigenschaften vorher. Die eingeschränkte Nutzbarkeit ließ sich auch mit In-vitro-Vergleichen belegen.
Cardiac resynchronisation therapy (CRT) is a promising treatment option in patients with chronic heart failure. In this article the roles of semi-invasive esophageal left-heart electrocardiography and functional cardiac nuclear imaging in the field of CRT are highlighted, as the combination of both could be a favourable diagnostic approach in special cardiac situations. Also original esophageal left heart electrogram data of exemplary CRT patients is presented.